HK1218839A1 - 通過使用來自普雷沃氏菌屬的至少種細菌菌株治療肥胖、代謝綜合征、 型糖尿病、心血管疾病、痴呆、阿爾茨海默病和炎性腸病 - Google Patents

通過使用來自普雷沃氏菌屬的至少種細菌菌株治療肥胖、代謝綜合征、 型糖尿病、心血管疾病、痴呆、阿爾茨海默病和炎性腸病

Info

Publication number
HK1218839A1
HK1218839A1 HK16106341.5A HK16106341A HK1218839A1 HK 1218839 A1 HK1218839 A1 HK 1218839A1 HK 16106341 A HK16106341 A HK 16106341A HK 1218839 A1 HK1218839 A1 HK 1218839A1
Authority
HK
Hong Kong
Prior art keywords
prevotella
dementia
obesity
disease
treatment
Prior art date
Application number
HK16106341.5A
Other languages
English (en)
Inventor
．比約克
．尼爾松
．貝克赫德
．科瓦切瓦-達特查裡
Original Assignee
Proprev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52008426&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1218839(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Proprev Ab filed Critical Proprev Ab
Publication of HK1218839A1 publication Critical patent/HK1218839A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/02—Products made from whole meal; Products containing bran or rough-ground grain
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/04—Products made from materials other than rye or wheat flour
    • A21D13/047—Products made from materials other than rye or wheat flour from cereals other than rye or wheat, e.g. rice
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/06—Products with modified nutritive value, e.g. with modified starch content
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/06—Products with modified nutritive value, e.g. with modified starch content
    • A21D13/062—Products with modified nutritive value, e.g. with modified starch content with modified sugar content; Sugar-free products
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/40—Products characterised by the type, form or use
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/40—Products characterised by the type, form or use
    • A21D13/42—Tortillas
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/40—Products characterised by the type, form or use
    • A21D13/43—Flatbreads, e.g. naan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16106341.5A 2013-06-03 2016-06-03 通過使用來自普雷沃氏菌屬的至少種細菌菌株治療肥胖、代謝綜合征、 型糖尿病、心血管疾病、痴呆、阿爾茨海默病和炎性腸病 HK1218839A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1350675 2013-06-03
PCT/SE2014/050650 WO2014196913A1 (en) 2013-06-03 2014-05-27 Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella

Publications (1)

Publication Number Publication Date
HK1218839A1 true HK1218839A1 (zh) 2017-03-17

Family

ID=52008426

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106341.5A HK1218839A1 (zh) 2013-06-03 2016-06-03 通過使用來自普雷沃氏菌屬的至少種細菌菌株治療肥胖、代謝綜合征、 型糖尿病、心血管疾病、痴呆、阿爾茨海默病和炎性腸病

Country Status (11)

Country Link
US (3) US10137157B2 (zh)
EP (1) EP3016527B1 (zh)
CN (1) CN105451576B (zh)
DK (1) DK3016527T3 (zh)
ES (1) ES2692162T3 (zh)
HK (1) HK1218839A1 (zh)
PL (1) PL3016527T3 (zh)
PT (1) PT3016527T (zh)
SG (1) SG11201510750XA (zh)
TR (1) TR201815566T4 (zh)
WO (1) WO2014196913A1 (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US20170100328A1 (en) * 2011-02-04 2017-04-13 Joseph E. Kovarik Bioadhesive Strip and Method of Using Same
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
WO2014091017A2 (en) * 2012-12-13 2014-06-19 Metabogen Ab Identification of a person having risk for developing type 2 diabetes
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
CN106663137B (zh) 2014-04-28 2020-07-10 耶达研究及发展有限公司 用于预测对食物的反应的方法和装置
FI127671B (en) * 2014-05-28 2018-11-30 Filip Scheperjans Procedure for the diagnosis of Parkinson's disease
US20170360853A1 (en) * 2015-01-07 2017-12-21 Ecole Polytechnique Federale De Lausanne (Epfl) Gastro-Intestinal Biomarkers for Diagnosis and Therapies of Proteinopathies
CN107847531A (zh) * 2015-05-21 2018-03-27 耶达研究及发展有限公司 用于促进健康的细菌群
CN110177885A (zh) 2016-12-23 2019-08-27 默多克儿童研究所 用于确定和最小化婴儿过敏发生可能性的方法和组合物
WO2018136884A1 (en) * 2017-01-23 2018-07-26 The Regents Of The University Of California Compositions and methods for treating obesity and inducing weight loss
EP3369423A1 (en) * 2017-03-01 2018-09-05 Reminisciences Synbiotic composition and its use for preventing and/or treating neurodegenerative disorders
BR112020004347A2 (pt) * 2017-09-08 2020-09-08 Evelo Biosciences, Inc. vesículas extracelulares de prevotella
MA50086A (fr) 2017-09-08 2020-07-15 Evelo Biosciences Inc Vésicules extracellulaires (ev) bactériennes
KR102118993B1 (ko) * 2018-03-06 2020-06-05 주식회사 엠디헬스케어 프레보텔라 속 세균 유래 나노소포 및 이의 용도
CN110638838B (zh) * 2018-06-26 2021-07-06 瑞微（深圳）生物科技有限公司 阿克曼粘细菌或普氏菌在制备用于增强抗肿瘤免疫功能的药物中的应用
CN112584847A (zh) * 2018-08-20 2021-03-30 默多克儿童研究所 行为治疗
US20220031765A1 (en) 2018-11-30 2022-02-03 Ospedale San Raffaele S.R.L. Bacterial strains for medical uses
CN111450124B (zh) * 2019-01-18 2022-03-15 瑞微（深圳）生物科技有限公司 阿克曼粘菌或普氏菌在增加肿瘤微环境γδT细胞积累并增强抗肿瘤免疫功能药物中的应用
WO2020176624A1 (en) * 2019-02-26 2020-09-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Probiotics and probiotic compositions having modified carbohydrate metabolism
AU2021246535A1 (en) * 2020-04-03 2022-10-27 International N&H Denmark Aps Composition comprising bacterial strains for improving metabolic health
KR20230048337A (ko) * 2020-07-21 2023-04-11 에벨로 바이오사이언시즈, 인크. 염증성 질환에 대한 경구 요법으로서의 프레보텔라 히스티콜라 균주 c
TW202227110A (zh) * 2020-09-21 2022-07-16 美商艾弗洛生物科技股份有限公司 用棲組織普雷沃菌調節免疫反應之組成物及方法
KR20240144112A (ko) * 2021-12-02 2024-10-02 마블바이옴 인코포레이티드 미주신경 관련 질환, 장애 및 병태를 치료하기 위한 마이크로바이옴 조성물, 성분 또는 대사산물의 방법 및 용도
WO2023201092A1 (en) * 2022-04-14 2023-10-19 Washington University Prevotella copri formulations and methods of use
CN117187342B (zh) * 2022-09-27 2024-07-26 合肥瀚微生物科技有限公司 一种基于质谱检测肠道内单个细菌代谢物的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
WO2010122106A1 (en) 2009-04-23 2010-10-28 Bacterfield International S.A. Extruded food products comprising probiotic micro-organisms
US8617536B2 (en) * 2009-10-30 2013-12-31 Mayo Foundation For Medical Education And Research Prevotella histicola preparations and the treatment of autoimmune conditions
SG191418A1 (en) 2010-12-29 2013-07-31 Nestec Sa A nutritional composition comprising fiber and probiotics for reducing stressrelated intestinal symptoms
WO2012142605A1 (en) 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
CN102744320B (zh) 2011-04-21 2014-11-19 中国北车集团大同电力机车有限责任公司 冲压模具
KR20140082964A (ko) * 2011-10-11 2014-07-03 아힘 바이오테라퓨틱스 에이비 혐기성 조건으로 배양된 인간 장내 미생물을 포함하는 조성물
CN102743420A (zh) 2012-06-06 2012-10-24 上海交通大学 改善肠道菌群结构的方法及应用

Also Published As

Publication number Publication date
EP3016527B1 (en) 2018-07-25
EP3016527A4 (en) 2017-03-15
US20240285695A1 (en) 2024-08-29
US20190151376A1 (en) 2019-05-23
DK3016527T3 (en) 2018-11-12
WO2014196913A1 (en) 2014-12-11
ES2692162T3 (es) 2018-11-30
TR201815566T4 (tr) 2018-11-21
CN105451576A (zh) 2016-03-30
EP3016527A1 (en) 2016-05-11
SG11201510750XA (en) 2016-02-26
WO2014196913A9 (en) 2017-03-02
CN105451576B (zh) 2020-07-14
PL3016527T3 (pl) 2019-02-28
US10137157B2 (en) 2018-11-27
PT3016527T (pt) 2018-11-09
US20160113972A1 (en) 2016-04-28

Similar Documents

Publication Publication Date Title
HK1218839A1 (zh) 通過使用來自普雷沃氏菌屬的至少種細菌菌株治療肥胖、代謝綜合征、 型糖尿病、心血管疾病、痴呆、阿爾茨海默病和炎性腸病
IL244668A0 (en) Preparations and formulations for the prevention and treatment of diabetes and obesity, and methods for their production and use in the control of glucose and calories
PH12015501291B1 (en) Functionalized exendin-4 derivatives
LT3105213T (lt) Dihidrobenzofurano junginiai, tinkami naudoti diabeto ir nutukimo gydymui
WO2013149258A3 (en) Compositions and methods for treating or preventing metabolic syndrome disorders
EP3104854A4 (en) Mast cell stabilizers for lung disease treatment
BR212012003383U2 (pt) sola com ferragens articuladas em sua periferia.
EP2579876A4 (en) THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR PREDICT
EP2646032A4 (en) THERAPEUTIC TREATMENT OF METABOLIC SYNDROME AND TYPE 2 DIABETES, ADIPOSITAS OR PREDICTES
WO2016106343A8 (en) Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory bowel disease
EP3054977A4 (en) Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
HK1244216A1 (zh) 治療2型糖尿病患者
EP2967060A4 (en) METHODS OF DIAGNOSING, SELECTING AND TREATING DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENIC BACTERIA
IL249750A0 (en) Disease control of bacterial pathogens in plants that cause citrus fruit spot and rice wilt
HK1200090A1 (zh) 心血管疾病防治及生物技術保養保健材料
Verbeke et al. Beginselen Relatievermogensrecht 2 (Principles of Relational Property Law-)
Smoryñski Nonstandard models of arithmetic: course notes Utrecht, Fall 1978
Doneria et al. Evaluation of Metabolic Properties of Functional Starter Culture
Guang-Rong et al. Interpretation of the Relationship between Dissemination Effect Research and Learning Theory
Aguiyi Of Nature, Knowledge and Health: The Molecular Basis of Natural Products Development.
AU5064P (en) DBA-Aurora Triticum turgidum subsp. Durum
TH148794B (th) วิธีการสำหรับการผลิตพาสต้าปรุงสุกและแช่แข็ง
GB201402288D0 (en) Novel cyclic compounds and improved treatments for cardiac and cardiovascular disease
TH152099B (th) เตียงสำหรับกายภาพ
CN302440290S (zh) 实验用操作屏